Genomic Study Identifies Four-Gene Signature Linked to Poor Stomach Cancer Prognosis

Findings reveal genetic mutations in BRCA2, CDH1, RHOA, and TP53 as key markers, paving the way for tailored treatments and diagnostic advancements.